首页> 外文期刊>Pharmacology & Pharmacy >Evolution of Biochemical Effects of Byetta? in Type 2 Diabetics with Cardiovascular Risk
【24h】

Evolution of Biochemical Effects of Byetta? in Type 2 Diabetics with Cardiovascular Risk

机译:拜塔的生化作用的演变? 2型糖尿病患者的心血管风险

获取原文
       

摘要

The objective of this study was to examine longitudinally the effects of exenatide on different physical and biochemical markers, evaluated in adult type 2 diabetic patients with cardiovascular risk. Data were recorded from 10 patients who attended the outpatient primary care health center Mariano Iago Yecla, Murcia province, Spain in the period of December 2009 to October 2011 and who were treated with Byetta?. Differences were statistically significant (p 0.05) in HbA1c from the third month of treatment, and trends of decrease in body weight from the third week of treatment. There was a significant and better glycemic control. Overall effect was interpreted as a sensitizer drug of the parameters evaluated. Randomized studies are recommended with a minimum follow-up of 2 years, to see if the results are maintained over time.
机译:这项研究的目的是从纵向检查艾塞那肽对不同物理和生化指标的影响,并在患有心血管疾病的成人2型糖尿病患者中进行了评估。记录的数据来自2009年12月至2011年10月间在西班牙穆尔西亚省门诊初级保健中心Mariano Iago Yecla接受过Byetta?治疗的10位患者。从治疗的第三个月开始,HbA1c的差异具有统计学意义(p 0.05),从治疗的第三周开始,体重下降趋势。血糖控制明显改善。总体效果被解释为所评估参数的敏化药物。建议进行随机研究,至少随访2年,以查看结果是否随时间保持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号